Kezar Life Sciences, Inc. (KZR) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 67.56M | 75.73M | 94.5M | 104.7M | 120.32M | 137.49M | 156.38M | 167.62M | 185.61M | 206.95M | 230.52M | 243.5M |
| Cash & Short-Term Investments | 66.23M | 71.88M | 90.22M | 100.85M | 114.36M | 132.25M | 148.39M | 164.18M | 179.8M | 201.37M | 218.21M | 236.59M |
| Cash Only | 66.23M | 71.88M | 38.94M | 34.37M | 37M | 41.75M | 34.86M | 28.28M | 33.03M | 35.49M | 26.5M | 28.11M |
| Short-Term Investments | 0 | 0 | 51.28M | 66.48M | 77.36M | 90.5M | 113.53M | 135.91M | 146.77M | 165.88M | 191.71M | 208.48M |
| Accounts Receivable | 0 | 1.93M | 2M | 2M | 2.2M | 424K | 1.09M | 1.69M | 3.06M | 2.29M | 7M | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | 92 | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 514K | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.33M | 1.39M | 276K | 182K | 828K | 351K | 787K | 976K | 1.98M | 251K | 935K | 933K |
| Total Non-Current Assets | 436K | 915K | 3.22M | 4.42M | 4.94M | 7.19M | 7.71M | 12.3M | 13.52M | 14.29M | 18.81M | 19.88M |
| Property, Plant & Equipment | 436K | 915K | 3.23M | 3.75M | 4.27M | 4.78M | 5.29M | 5.78M | 8.02M | 8.69M | 12.47M | 13.31M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | 0.54x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 674K | 674K | 2.42M | 2.42M | 6.52M | 5.5M | 5.59M | 6.33M | 6.56M |
| Total Assets | 68M | 76.65M | 97.73M | 109.12M | 125.26M | 144.68M | 164.09M | 179.92M | 199.13M | 221.24M | 249.33M | 263.38M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | 0.03x | - |
| Asset Growth % | -45.71% | -47.02% | -40.44% | -39.35% | -37.1% | -34.6% | -34.19% | -31.69% | -29.93% | -26.15% | -18.19% | -17.05% |
| Total Current Liabilities | 2.76M | 6.57M | 13.38M | 14.37M | 16.96M | 20.33M | 20.43M | 17.5M | 16.16M | 17.74M | 16.67M | 13.74M |
| Accounts Payable | 273K | 507K | 911K | 1.16M | 1.97M | 3.65M | 3.46M | 2.26M | 5.06M | 8.25M | 3.12M | 2.49M |
| Days Payables Outstanding | - | 370.61 | - | - | - | - | - | - | 2.33K | 1.87K | 928.6 | - |
| Short-Term Debt | 1.35M | 2.33M | 8.54M | 9.1M | 5.22M | 5.22M | 3.91M | 2.61M | 1.3M | 3.01M | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.43M | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.14M | 3.67M | 1.81M | 2.37M | 1.2M | 2.72M | 7.54M | -632K | 4.96M | 2.77M | 2.97M | 2.1M |
| Current Ratio | 24.46x | 11.52x | 7.06x | 7.29x | 7.09x | 6.76x | 7.65x | 9.58x | 11.49x | 11.66x | 13.83x | 17.73x |
| Quick Ratio | 24.46x | 11.52x | 7.06x | 7.29x | 7.09x | 6.74x | 7.65x | 9.58x | 11.49x | 11.66x | 13.83x | 17.73x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 1.37M | 2.97M | 5.23M | 7.44M | 9.61M | 11.74M | 13.85M | 15.92M | 16.66M | 17.36M |
| Long-Term Debt | 0 | 0 | 1.37M | 2.63M | 3.87M | 5.11M | 6.35M | 7.59M | 8.83M | 10.07M | 10.01M | 9.95M |
| Capital Lease Obligations | 0 | 0 | 0 | 344K | 1.35M | 2.33M | 3.26M | 4.15M | 5.02M | 5.85M | 6.65M | 7.41M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 2.76M | 6.57M | 14.75M | 17.34M | 22.19M | 27.77M | 30.04M | 29.24M | 30.01M | 33.66M | 33.33M | 31.1M |
| Total Debt | 1.35M | 2.33M | 9.91M | 12.07M | 14.11M | 16.18M | 16.91M | 17.61M | 18.29M | 18.93M | 19.55M | 20.15M |
| Net Debt | -64.88M | -69.55M | -29.02M | -22.29M | -22.89M | -25.57M | -17.95M | -10.67M | -14.75M | -16.56M | -6.94M | -7.96M |
| Debt / Equity | 0.02x | 0.03x | 0.12x | 0.13x | 0.14x | 0.14x | 0.13x | 0.12x | 0.11x | 0.10x | 0.09x | 0.09x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | -19.87x | -44.38x | -46.71x | -50.97x | -49.40x | -52.73x | -53.15x | -79.85x | -57.34x | -62.14x |
| Total Equity | 65.24M | 70.07M | 82.98M | 91.79M | 103.07M | 116.92M | 134.05M | 150.69M | 169.12M | 187.57M | 215.99M | 232.28M |
| Equity Growth % | -36.71% | -40.07% | -38.1% | -39.09% | -39.06% | -37.67% | -37.94% | -35.13% | -33.02% | -30.5% | -23.73% | -21.89% |
| Book Value per Share | 8.88 | 9.58 | 11.33 | 12.55 | 14.11 | 16.02 | 1.84 | 2.07 | 2.32 | 2.58 | 2.97 | 3.21 |
| Total Shareholders' Equity | 65.24M | 70.07M | 82.98M | 91.79M | 103.07M | 116.92M | 134.05M | 150.69M | 169.12M | 187.57M | 215.99M | 232.28M |
| Common Stock | 7K | 7K | 7K | 7K | 7K | 7K | 7K | 73K | 73K | 73K | 73K | 73K |
| Retained Earnings | -496.29M | -490.53M | -475.99M | -464.76M | -451.06M | -434.5M | -414.28M | -393.97M | -372.42M | -350.76M | -318.5M | -295.4M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 14K | -267K | -232K | -162K | 107K | -385K | -355K | -130K | -687K | -830K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |